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Abstract
Objectives Circulating 25-hydroxyvitamin D (25-OHD)
is associated with improved cancer prognosis in some
studies, yet it may be a surrogate marker for physical
activity. We investigated the associations of leisure-time
physical activity (LTPA) with circulating 25-OHD levels in
cancer survivors, and determined whether associations
differ by indoor and outdoor activity.
Design Cross-sectional study.
Setting The US National Health and Nutrition Examination
Survey (NHANES).
Participants Cancer survivors with available data on
demographic information, measures of adiposity, smoking
history, self-reported LTPA and circulating 25-OHD levels in
five waves of NHANES (2001–2010).
Main outcomes measures Circulating 25-OHD levels.
Results Multivariable linear regression and logistic
regression models were used to evaluate the associations
of self-reported LTPA with 25-OHD, adjusting for potential
confounders. Due to the differences in LTPA measure,
the analyses were conducted separately for 2001–2006
and 2007–2010 data. We further estimated associations
by indoor and outdoor activity in the 2001–2006 data.
There were 1530 cancer survivors (mean age=60.5
years, mean body mass index=28.6 kg/m2). The prevalent
cancer sites were breast (19.3%), prostate (18.8%), cervix
(10.4%) and colon (8.6%). Compared with inactive cancer
survivors, being physically active was associated with
higher circulating 25-OHD levels (8.07 nmol/L, 95% CI
4.63 to 11.52) for 2001–2006 data. In the mutually
adjusted model, higher outdoor activity (5.83 nmol/L,
95% CI 1.64 to 10.01), but not indoor activity (2.93 nmol/L,
95% CI −1.80 to 7.66), was associated with statistically
significantly higher 25-OHD levels. The interaction
between indoor and outdoor activities was, however,
not significant (p=0.29). The only statistically significant
association seen in the 2007–2010 data was among
obese cancer survivors.
Conclusion Physical activity, particularly outdoor activity,
is associated with higher 25-OHD levels in cancer
survivors. In view of the possible beneficial effects of
vitamin D on cancer prognosis, engaging in outdoor

Strengths and limitations of this study
►► To the best of our knowledge, this is the first study to

investigate the association of leisure-time physical
activity (LTPA) with circulating 25-hydroxyvitamin
D (25-OHD) levels in cancer survivors. We further
compared associations by outdoor and indoor LTPA.
►► The current study pooled data from cancer survivors
in a nationally representative adult sample in the
USA.
►► This study controlled for a range of factors that are
known to affect circulating 25-OHD levels.
►► Study limitations include the following: (1) the crosssectional nature makes it impossible to determine
a causal association; (2) season, an important
determinant of 25-OHD levels, was categorised
into two (winter and summer, rather than winter,
summer, fall and spring); and (3) physical activity
was self-reported.

physical activity could provide clinically meaningful
increases in 25-OHD levels among cancer survivors.

Background
There are >15.5 million cancer survivors
in the USA and the number is expected
to rise to 20 million by 2026.1 Identifying
factors, particularly modifiable factors, that
improve prognosis and survival in this rapidly
expanding demographic group is, therefore,
a high priority.
There is emerging evidence that vitamin D
status is associated with improved cancer prognosis and survival, particularly colorectal and
breast cancers.2–5 Circulating 25-hydroxyvitamin D (25-OHD) is the best indicator
of overall vitamin D status because it has a
long half-life, is unregulated by homeostatic
systems in the body and reflects total vitamin
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D from multiple determinants.6–9 However, it has been
suggested that circulating 25-OHD level may be a surrogate or biological marker for lifestyle factors that impact
cancer prognosis, notably physical activity.2 10 11 Physical
activity, before and after cancer diagnosis, is associated
with reduced mortality in cancer survivors,12–14 although
the underlying mechanisms are still being elucidated.
In cancer-free population, leisure-time physical activity
(LTPA) is associated with an increase in circulating
25-OHD levels, which is thought to reflect exposure to
sunlight, a major determinant of circulating 25-OHD
levels.15 In support, studies have reported higher 25-OHD
levels for the same amount of outdoor compared with
indoor physical activity,16 although others have not.17
Nevertheless, it has also been shown that physical
activity and sun exposure may have independent effects
on circulating 25-OHD levels, suggesting that indoor
physical activity might be sufficient to increase circulating
25-OHD levels through its effect on 25-OHD metabolism,
such as 1,25-dihydroxyvitamin.18–21
To the best of our knowledge, no study has investigated the associations of physical activity with circulating
25-OHD levels in cancer survivors. Because physical
activity declines after cancer diagnosis, findings in cancerfree population may not apply to cancer survivors. Using
data from the National Health and Nutrition Examination
Survey (NHANES), our objectives are to (1) investigate
the associations of LTPA with circulating 25-OHD levels
in cancer survivors, and (2) determine whether associations differ by indoor and outdoor physical activity. Study
findings could have implications for public health recommendations in cancer survivors because physical inactivity
and vitamin D insufficiency are prevalent among cancer
survivors.22 23
Methods
Study population
The NHANES was designed to provide cross-sectional estimates on the prevalence of health, nutrition and potential
risk factors among the civilian non-institutionalised US
population up to 85 years of age.24 In brief, NHANES
surveys a nationally representative complex, stratified,
multistage, probability clustered sample of about 5000
participants each year in 15 counties across the country.
The NHANES obtained approval from the National
Center for Health Statistics Research Ethics Review Board
and the participants provided written consent.
We extracted demographic information, measures of
adiposity, smoking history, self-reported LTPA, circulating
25-OHD levels and cancer diagnosis, and combined
them into a single data set for each data collection wave.
Participants were considered as cancer survivors if they
answered ‘yes’ to the question ‘Have you ever been
told by a doctor or other health professional that you
had cancer or a malignancy of any kind?’ We excluded
participants who had non-melanoma skin cancer. This
interview question was only given to men and women 20
2

years or older, and subsequently restricted the analysed
sample to adult cancer survivors. We created a single data
set for each wave of data from NHANES in 2001–2002,
2003–2004, 2005–2006, 2007–2008 and 2009–2010, and
excluded those who were never diagnosed with cancer or
were pregnant (figures 1 and 2).
Circulating 25-OHD levels
The process of blood collection is detailed in the NHANES
Laboratory/Medical Technologist Procedures Manual.25
Participants who received chemotherapy within the last
4 weeks were excluded from blood collection in the
NHANES study. Blood samples were collected, processed,
stored and shipped to University of Washington, Seattle
for testing. The lab method measuring 25-OHD for 2007–
2010 changed from 2005 to 2006 and earlier in NHANES,
and has been described previously.26 Briefly, circulating
25-OHD concentrations were measured at the National
Center for Environmental Health, Centers for Disease
Control and Prevention, Atlanta, Georgia, using the
DiaSorin RIA kit (Stillwater, Minnesota, USA) between
2001 and 2006. We converted the 25-OHD data in 2001–
2006 using provided regression to equivalent 25-OHD
measurement from a standardised liquid chromatography-tandem mass spectrometry method, which was used
in the analysis of 25-OHD in NHANES 2007–2010 data.
This standardisation procedure therefore ensures that
25-OHD data are comparable between 2001–2006 and
2007–2010.
Sociodemographic characteristics
Sociodemographic characteristics including age, sex,
race and ethnicity, and smoking status were extracted.
Based on self-reported race and ethnicity, participants
were classified into one of the three racial/ethnic groups:
non-Hispanic white, non-Hispanic black, and Hispanic
and others. We classified participants into three groups:
never smokers (did not smoke 100 cigarettes and do not
smoke now), former smokers (smoked 100 cigarettes in
life and do not smoke now) and current smokers (smoked
100 cigarettes in life and smoke now).
Body mass index
Weight and height were measured at the time of physical
examination in a mobile examination centre (MEC) or
in the participant’s home. The measurements followed
standard procedures and were carried out by trained
technicians using standardised equipment. Body mass
index (BMI) was calculated as weight in kg/(height in
metres).2 We categorised study participants into standard
BMI categories: underweight (<18.5 kg/m2), normal
weight (18.5–24.9 kg/m2), overweight (25.0–29.9 kg/
m2) and obese (≥30.0 kg/m2). For analytic purposes, we
combined those who were underweight and those who
had normal weight into one category (≤25 kg/m2).
Season of blood draw
Blood samples were collected at the time of physical
examination in an MEC or in the participant’s home.
Yang L, Toriola AT. BMJ Open 2017;7:e016064. doi:10.1136/bmjopen-2017-016064
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Figure 1 Participants’ flow chart: cancer survivors aged 20 years or older from the National Health and Nutrition Examination
Survey (NHANES) (2001–2006). 25-OHD, 25-hydroxyvitamin D.

Season of blood draw was determined from the documented month of physical examination. Months were
reported in two groups: 1 November through 30 April, or
1 May through 31 October, and classified into winter or
summer, respectively.16

Self-reported LTPA
The assessment on self-reported physical activity for
2007–2010 changed from 2005 to 2006 and earlier. There

is no conversion provided between the two assessments;
therefore, analyses for LTPA were conducted separately
for the 2001–2006 and 2007–2010 data.
In the 2001–2006 data, participants self-reported
specific LTPA in the past 30 days from a list of 48 activities,
if they engaged in certain activities, and the frequencies
and durations of these activities. Each activity was coded
into a metabolic equivalent task (MET) score based on the
2011 Compendium of Physical Activities, a valid and globally used instrument to quantify the energy expenditure
of physical activity in adults.28 For each reported activity,
MET-minutes per week (MET-min/week) were calculated
by multiplying the MET value of each reported activity by
the minutes spent in the activity per 7 days. Overall LTPA
was summarised as the total MET-min/week of all reported
activities.29 Cancer survivors were classified as inactive (0
MET-min/week), insufficiently active (<750 MET-min/
week) and sufficiently active (≥750 MET-min/week)
based on the standard definition.29 In addition, we
categorised each of the 48 listed activities into outdoor
(eg, walking, jogging, fishing) or indoor (eg, aerobics,
bowling, weights) activity. Activities that could be either
indoor or outdoor (eg, bicycling, swimming) were classified as indoor to ensure a conservative estimation of
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Dietary vitamin D supplement use
Information on dietary vitamin D supplement was
retrieved from the 30-day dietary supplement data set in
the 2001–2006 and 2007–2010 data. In the 2001–2006
data set, we obtained data on individual product for
participants who reported taking vitamin supplement,
and linked to the Dietary Supplements Ingredient Database.27 Products’ ingredients that contained vitamin D
were aggregated for each participant, and then categorised into a binary variable (yes/no) for dietary vitamin
D supplement use assessment. In 2007–2010 data, aggregated information on dietary supplement use (including
vitamin D supplement use) was available, thus was used
to determine participants’ dietary vitamin D supplement
use (yes/no).
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Figure 2 Participants’ flow chart: cancer survivors aged 20 years or older from the National Health and Nutrition Examination
Survey (NHANES) (2007–2010). 25-OHD, 25-hydroxyvitamin D.

the associations between outdoor LTPA and 25-OHD.
Both indoor and outdoor LTPAs were summarised in
MET-min/week, then classified as inactive (0 MET-min/
week), insufficiently active (<450 MET-min/week) and
sufficiently active (≥450 MET-min/week). A cut-off
lower than 750 MET-min/week was used for indoor and
outdoor activities, given they are subsets of overall LTPA.
We used 450 MET-min/week as the cut-off given that it is
the minimal goal of weekly LTPA.29
In the 2007–2010 data, participants self-reported their
daily activities, leisure-time activities and sedentary activities using questions based on the Global Physical Activity
Questionnaire.30 Levels of LTPA were calculated as the
minutes per week that participants reported participating in moderate-to-vigorous-intensity physical activity
(MVPA). Participants reported the number of days and
minutes spent in moderate recreational and vigorous
recreational activities in a typical week by answering
the following questions: ‘In a typical week, on how
many days do you do vigorous-intensity sports, fitness or
recreational activities?’ ‘Minutes vigorous recreational
activities’, and ‘In a typical week, on how many days do
you do moderate-intensity sports, fitness or recreational
activities?’ ‘Minutes moderate recreational activities’.

We summarised the total number of minutes for both
activities, where the number of minutes spent in vigorous-intensity physical activity was doubled and added to
the number of minutes of moderate-intensity physical
activity to approximately equal the MET value.31 Cancer
survivors were classified as inactive (0 min/week MVPA),
insufficiently active (<150 min/week MVPA) and sufficiently active (≥150 min/week MVPA) based on the
physical activity guidelines for cancer survivors.32

4
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Statistical analysis
Survey analysis procedures were used to account for the
sample weights (MEC exam weight), stratification and
clustering of the complex sampling design to ensure
nationally representative estimates. Information on sociodemographic characteristics, weight, height, season of
blood draw and self-reported LTPA was complete among
cancer survivors who had available data on circulating
25-OHD levels. We calculated the descriptive statistics
for participants’ characteristics and LTPA categories by
25-OHD levels in quintiles separately in 2001–2006 data
and 2007–2010 data. We summarised weighted means
and SEs for continuous variables, and weighted proportions for categorical variables.
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We estimated linear associations between LTPA and
25-OHD levels in both 2001–2006 and 2007–2010 data.
The multivariable linear regression models for LTPA
were adjusted for age, sex, race, BMI, smoking status
and season of blood draw. In the 2001–2006 data, we
further estimated the linear associations between LTPA
and 25-OHD separately by indoor and outdoor activities. Χ2test indicated significant difference (p<0.001)
between indoor and outdoor activities. In the multivariable linear regression models, we simultaneously
adjusted for both activities. We tested for differences
between the indoor and outdoor effects by including
both in the regression model and testing for interaction. We examined the normality of residuals by kernel
density estimate and standardised normal probability
plots for all the linear regression models. Continuous
25-OHD data were categorised as low (<50 nmol/L) and
high (≥50 nmol/L) 25-OHD based on definitions of
vitamin D insufficiency.30
To calculate the prevalence ratios (PRs) of high
25-OHD level (≥50 nmol/L) across LTPA categories, we
first calculated prevalence ORs (PORs) for each category
in multivariable logistic regression models. Since the
PORs do not approximate the PRs for common outcome
(25-OHD ≥50 nmol/L), we used the baseline prevalence
to correct the PORs and 95% CIs based on existing
method to obtain reliable PR estimates.33 We further
conducted the following sensitivity analyses: (1) using
BMI as a continuous variable in the regression models;
(2) stratification by BMI category; (3) classifying activities that could be either indoor or outdoor (eg, bicycling,
swimming) as outdoor activities; and (4) classifying activities that could be either indoor or outdoor (eg, bicycling,
swimming) as half–half (MET-min/week) to indoor and
outdoor activities.
All statistical significance was set at p<0.05. All statistical
analyses were performed using Stata V.14.0.
Results
Our study population consisted of 1530 cancer survivors who had data on circulating 25-OHD levels. The
most prevalent cancer sites were breast cancer (19.3%),
prostate (18.8%), cervix (10.4%) and colon (8.6%).
Participants’ mean age at the time of baseline examination was 60.5 years, and their mean BMI was 28.6 kg/
m2. Circulating 25-OHD levels were significantly higher
among those who reported dietary vitamin D supplement
use than those who did not in both 2001–2006 (68.82 vs
56.74 nmol/L, p<0.001) and 2007–2010 data (83.73 vs
60.88 nmol/L, p<0.001). We observed statistically significant differences in circulating 25-OHD levels for most
characteristics, except for age and sex (2001–2006 in
table 1 and 2007–2010 in table 2). Cancer survivors who
were obese, non-Hispanic black or smokers had lower
25-OHD levels than those who had normal weight, were
non-Hispanic white/Hispanic and were non-smokers,
respectively.
Yang L, Toriola AT. BMJ Open 2017;7:e016064. doi:10.1136/bmjopen-2017-016064

Associations between LTPA and circulating 25-OHD levels
Tables 3 and 4 summarise both the non-adjusted and
adjusted associations between LTPA and circulating
25-OHD in linear regression and logistic regression
models, respectively. Because LTPA measure differed
between 2001–2006 and 2007–2010 and there is no
conversion between the two, it is not possible to compare
the findings between two study phases directly. Cancer
survivors who were sufficiently active had higher circulating 25-OHD levels than those who were inactive in
univariate analyses, and these findings were maintained in
multivariable analyses in the 2001–2006 data, but not the
2007–2010 data. This translated to 8.07 nmol/L (95% CI
4.63 to 11.52) higher 25-OHD levels in 2001–2006 phase
in the multivariable-adjusted models. Furthermore, the
comprehensive data on a list of 48 activities collected in
2001–2006 allowed us to extend the analyses to compare
between indoor and outdoor LTPA in relation to 25-OHD
levels. In the non-adjusted models (table 3), higher levels
of indoor and outdoor LTPA both were associated with
higher 25-OHD levels. However, in multivariable-adjusted models (that also mutually adjusted for indoor
and outdoor LTPA), the association was only statistically significant among cancer survivors who engaged in
outdoor LTPA (5.83 nmol/L, 95% CI 1.64 to 10.01). The
interaction between indoor and outdoor activities was
not significant (p=0.29). Analyses using logistic regression models were supportive. Our findings were similar
when we classified activities that could be either indoor
or outdoor (eg, bicycling, swimming) as outdoor activities
(6.39 nmol/L, 95% CI 2.85 to 9.94), and classifying these
activities as half–half (MET-min/week) to indoor and
outdoor activities (7.26 nmol/L, 95% CI 2.88 to 11.64)
(data not shown).
Likewise, we observed similar results in sensitivity analyses using BMI as a continuous variable; higher 25-OHD
levels were associated with LTPA in the overall analyses
(7.74 nmol/L, 95% CI 4.53 to 10.95) and among those
who engaged in outdoor LTPA (5.82 nmol/L, 95% CI
1.69 to 9.95) (data not shown). In stratified analyses, associations of LTPA with higher circulating 25-OHD levels
were retained in the obese group in the 2001–2006 data
(7.10 nmol/L, 95% CI 2.51 to 11.70, outdoor LTPA) as well
as 2007–2010 data (13.91 nmol/L, 95% CI 3.86 to 23.96,
overall LTPA) (see online supplementary 1). The stratified analyses should, however, be interpreted cautiously
because the relatively small number of participants in the
different strata may not allow for very robust effect estimates. Outdoor LTPA was lower in non-Hispanic black
(69.2% inactive vs 51.5% inactive among non-Hispanic
whites, and 43.2% inactive among Hispanics) (data not
shown).
Discussion
We observed that being physically active was associated
with higher circulating 25-OHD levels in a nationally
representative sample of cancer survivors. Further
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analyses showed that the elevated 25-OHD levels were
only statistically significant among cancer survivors who
engaged in outdoor physical activity.
To the best of our knowledge, this is the first study to
evaluate the associations of physical activity with circulating 25-OHD levels in cancer survivors. Our findings
are, however, similar to what has been reported among
non-cancer participants enrolled in NHANES (1988–
1994).16 Scragg and Camargo reported a 9.6 nmol/L
increase in 25-OHD levels among participants who
engaged in outdoor LTPA compared with those who did
not engage in outdoor LTPA. The increase in 25-OHD
levels associated with outdoor LTPA is higher than what
we observed in our study population (5.83 nmol/L higher
25-OHD). This could be due to the different ways LTPA
was categorised. The most active group in their study
translates to participating daily in outdoor activity, while
only 5.6% (weighted proportion) of cancer survivors
in our sample achieved this physical activity level. To
compare at an equivalently active level, our findings of
a 5.83 nmol/L increase in cancer survivors are similar to
6.1 nmol/L higher 25-OHD level in individuals who were
at a similar activity level (engaged in 13–30 times outdoor
LTPA per month) reported by Scragg and Camargo.16
Data from trials have shown that each 40 IU of vitamin
D consumed increases serum 25-OHD concentrations
by 0.53 nmol/L in adults.34 The recommended dietary
vitamin D allowance for adults in the USA is 600 IU, which
is expected to increase circulating 25-OHD levels by
15 nmol/L. Thus, our findings (a 5.83 nmol/L increase)
suggest that engaging in outdoor LTPA could provide
clinically meaningful increases in 25-OHD levels among
cancer survivors. A more recent analysis using NHANES
2003–2006 data reported increasing level of 25-OHD
is associated with higher level of objectively measured
moderate-to-vigorous physical activity, but the association
was not stronger for outdoor LTPA compared with indoor
when using self-reported data.17
It is unclear whether physical activity has direct or
indirect effects on 25-OHD levels. Sun exposure is the
major determinant of circulating 25-OHD levels; hence,
it is possible that physical activity may indirectly impact
25-OHD levels through increased sun exposure associated with outdoor activity7 among active individuals,
yet few studies have measured activities specifically to
outdoor, or able to adjusted for sun exposure.16 17 35 36
On the other hand, physical activity may directly impact
25-OHD metabolism. Zittermann and colleagues18
reported higher calcium absorption rates and plasma
calcritrol levels in exercise-trained young men compared
with age-matched sedentary controls. Similarly, in a small
study, young men who underwent muscle-building exercise (indoor) for at least 1 year had higher circulating
25-OHD, Gla protein and 1,25-dihydroxyvitamin levels
compared with age-matched controls who received
constant daily diet same as the exercise group.20 However,
whether this mechanism operates in cancer survivors
is unclear because of the physiological, biological and
7
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43.0
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p Value

Sociodemographic characteristics and LTPA of cancer survivors aged 20 years or older from the NHANES (2007–2010), by circulating 25-OHD levels (n=737)

2007–2010
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Table 3 Associations between LTPA and circulating 25-OHD level from unadjusted and multivariable linear regression models
among cancer survivors aged 20 years or older from the NHANES (2001–2010)
Circulating 25-OHD (nmol/L)
2001–2006* (n=793)

UnadjustedBeta coefficient (95% CI)

Adjusted†Beta coefficient
(95% CI)

LTPA
 Inactive

Reference

Reference

 Insufficiently active

7.36 (2.65 to 12.07)

3.63 (−0.69 to 7.95)

 Sufficiently active

12.16 (7.29 to 17.04)

8.07 (4.63 to 11.52)

 p For trend

<0.001

<0.001

 Inactive

Reference

Reference

 Insufficiently active

9.10 (5.15 to 13.04)

6.17 (1.74 to 10.59)

 Sufficiently active

8.84 (4.16 to 13.52)

5.83 (1.64 to 10.01)

 p For trend

<0.001

0.005

 Inactive

Reference

Reference

 Insufficiently active

3.15 (−1.63 to 7.94)

−1.22 (−4.97 to 2.52)

 Sufficiently active
 p For trend

8.22 (2.50 to 13.93)
0.004

2.93 (−1.80 to 7.66)
0.23

Outdoor physical activity

Indoor physical activity

Circulating 25-OHD (nmol/L)
2007–2010* (n=737)

UnadjustedBeta coefficient (95% CI)

Adjusted†Beta coefficient(95%
CI)

LTPA
 Inactive

Reference

Reference

 Insufficiently active

8.80 (−2.67 to 20.26)

5.70 (−4.19 to 15.6)

 Sufficiently active
 p For trend

12.04 (5.24 to 18.84)
0.001

5.73 (−1.68 to 13.15)
0.11

*LTPA data analysed separately due to the changes in self-reported LTPA measures from wave 2005–2006 to wave 2007–2008.
†Adjusted for age, sex, race, body mass index, smoking status and dietary vitamin D supplement use.
25-OHD, 25-hydroxyvitamin D; LTPA, leisure-time physical activity; NHANES, National Health and Nutrition Examination Survey.

behavioural alterations associated with cancer and cancer
treatment.32
We observed statistically significant higher circulating
25-OHD levels associated with outdoor, but not with
indoor, LTPA in the mutually adjusted model. Nevertheless, no statistically significant interaction between indoor
and outdoor LTPA was observed. It is likely that LTPA
influences 25-OHD via multiple pathways, possibly both
an indirect effect due to sun exposure and a direct impact
on 25-OHD metabolism. However this warrants further
investigation using precise measures of physical activity37
and taking into consideration sun exposure and other
vitamin D metabolites.
We observed that obese cancer survivors who were
active had higher circulating 25-OHD levels. Obesity
is believed to induce low circulating 25-OHD levels
through volumetric dilution of vitamin D in the excessive
adipose tissue.38 Given that obese cancer survivors are at
higher risk of vitamin D deficiency compared with the
non-obese,39 40 the present findings suggested engaging in

physical activity might be particularly important to maintain or increase circulating 25-OHD levels among obese
cancer survivors. Future studies are needed to confirm
these findings using more precise measures of adiposity
(eg, body fat percentage) in a larger study population.
The association between LTPA and dietary vitamin D
supplement use appeared to differ between 2001–2006
data (p=0.19) and 2007–2010 data (p=0.03), although
the prevalence of dietary vitamin D supplement use was
similar in two study phases (51.4% vs 51.5%). In the
2007–2010 data, active cancer survivors are more likely
to report dietary vitamin D supplement use compared
with inactive ones. Thus, the non-significant findings of
LTPA and circulating 25-OHD levels could arise from the
change in self-reported LTPA measures from 2001–2006
to 2007–2010 data.
The main strength of this analysis is pooling cancer
survivors from a nationally representative adult sample
in the USA. We aggregated five waves’ data and achieved
a fairly sizeable sample. In addition, we controlled for a
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Table 4 Associations between LTPA and circulating 25-OHD level from unadjusted and adjusted logistic regression models
among cancer survivors aged 20 years or older from the NHANES (2001–2010)
2001–2006*
Reference
(n=259)

Circulating 25-OHD ≥50 nmol/L (n=534)
Circulating 25-OHD <50 nmol/L

UnadjustedPrevalence ratio
(95% CI)†

Adjusted‡Prevalence ratio
(95% CI)†

LTPA
 Inactive

Reference

Reference

 Insufficiently active

1.19 (1.02 to 1.33)

1.10 (0.88 to 1.27)

 Sufficiently active

1.36 (1.30 to 1.45)

1.32 (1.19 to 1.41)

 p For trend

<0.001

<0.001

 Inactive

Reference

Reference

 Insufficiently active

1.21 (1.10 to 1.30)

1.16 (1.01 to 1.27)

 Sufficiently active

1.24 (1.11 to 1.33)

1.22 (1.06 to 1.32)

 p For trend

0.001

0.009

 Inactive

Reference

Reference

 Insufficiently active

1.19 (0.99 to 1.33)

1.10 (0.87 to 1.27)

 Sufficiently active
 p For trend

1.21 (1.05 to 1.33)
0.006

1.07 (0.88 to 1.23)
0.32

2007–2010*

Circulating 25-OHD ≥50 nmol/L (n=531)

Outdoor physical activity

Indoor physical activity

UnadjustedPrevalence ratio
(95% CI)

Adjusted†Prevalence ratio
(95% CI)

LTPA
 Inactive

Reference

Reference

 Insufficiently active

1.15 (0.97 to 1.26)

1.14 (0.92 to 1.27)

 Sufficiently active
 p For trend

1.22 (1.07 to 1.30)
0.008

1.13 (0.90 to 1.27)
0.18

Reference
(n=206)

Circulating 25-OHD <50 nmol/L

*LTPA data analysed separately due to the changes in self-reported LTPA measures from wave 2005–2006 to wave 2007–2008.
†Prevalence ratio and 95% CIs were corrected using prevalence OR and prevalence of high 25-OHD level (≥50 nmol/L) in reference groups.
‡Adjusted for age, sex, race, body mass index, smoking status and dietary vitamin D supplement use.
25-OHD, 25-hydroxyvitamin D; LTPA, leisure-time physical activity; NHANES, National Health and Nutrition Examination Survey.

range of factors that are known to affect the circulating
25-OHD levels. Further, we were able to compare associations of LTPA with 25-OHD by outdoor and indoor LTPA,
thereby providing further insights on the associations of
LTPA with 25-OHD levels.
There are a number of limitations to this study. First,
the cross-sectional nature of this study makes it impossible to determine a causal association. The debate on
whether vitamin D deficiency is a risk factor for mortality
or an indicator of good health is ongoing.41 42 It is possible
that active cancer survivors were more active because of
better health status than those who were inactive. Thus,
the higher 25-OHD levels in active cancer survivors might
be an indicator of better overall health. Second, season,
an important determinant of 25-OHD levels, was only
available in two categories. Solar radiation, required for
skin to synthesise vitamin D, is weaker in winter compared
with summer. However, there were no statistically significant differences between winter (southern states) and

summer (northern states) 25-OHD levels in our study
population, probably owing to the timing of blood collection in each region. The NHANES study collected blood
samples in the southern states during winter and in the
northern states during summer. Third, we were not able
to conduct analyses stratified by cancer type or time since
diagnosis because of the limited number of individual
cancers. Finally, physical activity was self-reported. Participants who received chemotherapy within the last 4 weeks
were excluded from blood collection within the NHANES
study. Chemotherapy-associated reduction of circulating
25-OHD level has been documented previously.43–45
Therefore our findings might not be generalisable to
patients receiving chemotherapy.
Our findings of an association between LTPA and
25-OHD, which was stronger for outdoor LTPA compared
with indoor LTPA, have implications for public health
recommendations in cancer survivors. Although the
casual relationship of 25-OHD with cancer survival is yet
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unclear, strong evidence supports the benefits of physical activity in improved cancer survival and the quality
of life during survival.37 46 Our findings suggest that
25-OHD might be a surrogate marker of physical activity
that accounts for the direct and indirect effects of LTPA,
particularly outdoor.7 16 The proportion of cancer survivors in NHANES who did not engage in any LTPA was
high, especially in the 2007–2010 (53.3%) compared with
the 2001–2006 wave (38.3%). This observed decline in
LTPA might be attributed to the differences in measures
and may not reflect an actual change in LTPA levels, that
is, the 2001–2006 measure comprised 48 activity items
while the 2007–2010 measure queries general physical
activity participation. These differences in measures may
also contribute to the non-significant findings observed
in the 2007–2010 data. In fact, an increase in the physical activity level in the US population from 2001 to 2011
has been reported from the The Behavioral Risk Factor
Surveillance System (BRFSS) data,47 although this trend
may not hold true in cancer survivors. Guidelines from
the American Cancer Society32 and American College of
Sports Medicine48 suggest that cancer survivors should
follow the physical activity guidelines for Americans
with specific exercise programming adaptations based
on disease-related and treatment-related adverse effects.
However, physical activity levels in these populations are
critically low during and after treatment.49 Physical activity
interventions in cancer survivors may consider including
early morning (before 11:00) outdoor activities for about
15 min. Notably, given the well-documented differences
in cancer prognosis between non-Hispanic blacks and
other racial/ethnic groups, and the emerging associations of vitamin D with cancer prognosis, physical activity
interventions incorporating outdoor activities might be
particularly important for cancer survival among non-Hispanic blacks.
In conclusion, physical activity, particularly outdoor
physical activity, is associated with higher 25-OHD levels
in cancer survivors. This adds to the potential health
benefits of being physically active. Non-Hispanic black
cancer survivors, who are more likely to have vitamin D
deficiency, were less likely to engage in outdoor LTPA.
In view of the possible beneficial effects of vitamin D on
cancer prognosis, engaging in outdoor physical activity
could provide clinically meaningful increases in 25-OHD
levels among cancer survivors.
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